![Shankar Musunuri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shankar Musunuri
Directeur Général chez
OCUGEN, INC.
Fortune : 4 M $ au 30/06/2026
Profil
Shankar Musunuri founded Nuron Biotech, Inc. in 2009, where he worked as President, Chief Executive Officer & Director in 2013, Ocugen, Inc. in 2013, where he worked as Chairman & Chief Executive Officer, Ocugen, Inc. in 2013, where he is working as Chairman & Chief Executive Officer from 2023, and Ocugen OpCo, Inc. in 2013, where he is working as Executive Chairman & Chief Executive Officer from 2015.
Dr. Musunuri also currently works at OrthoCellix, Inc., as President & Secretary.
Dr. Musunuri also formerly worked at Pfizer Inc., as Senior Director-Global Technology Transfer from 1996 to 2010, Wyeth LLC, as Principal, and Amylin Pharmaceuticals, Inc., as Principal in 1996.
Dr. Musunuri received his doctorate degree from the University of Connecticut and Masters Business Admin degree from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUGEN INC 0,84 % | 20/04/2026 | 2 838 374 ( 0,84 % ) | 4 M $ | 30/06/2026 |
Postes actifs de Shankar Musunuri
| Sociétés | Poste | Début |
|---|---|---|
| OCUGEN, INC. | Directeur Général | 27/09/2019 |
Ocugen OpCo, Inc. | Directeur Général | 01/05/2015 |
Anciens postes connus de Shankar Musunuri
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/01/2010 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 01/01/1996 |
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Directeur Général | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | - |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Fondateur | - |
Formation de Shankar Musunuri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Ocugen OpCo, Inc. |
Choisissez Zonebourse 
